Characterisation of novel AKT inhibitor in treatment of androgen sensitive prostate cancer

david cochrane, katie o'donovan, Heather Nesbitt, Stephanie McKeown, Jenny Worthington, martin o'rourke, Iain James, Declan McKenna

Research output: Chapter in Book/Report/Conference proceedingConference contributionpeer-review

Fingerprint

Dive into the research topics of 'Characterisation of novel AKT inhibitor in treatment of androgen sensitive prostate cancer'. Together they form a unique fingerprint.

Chemical Compounds